Common Stock, Shares, Outstanding of PLUS THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
PLUS THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • PLUS THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 138,675,856, a 2252% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 138,675,856 +132,779,523 +2252% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 131,605,544 +125,709,211 +2132% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 92,180,007 +86,475,788 +1516% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 16,999,626 +12,735,395 +299% 31 Mar 2025 10-Q 30 May 2025 2025 Q1
Q4 2024 5,896,333 +1,452,236 +33% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 5,896,333 +1,373,677 +30% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 5,704,219 +2,824,599 +98% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 4,264,231 -31,859,602 -88% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 4,444,097 +2,204,005 +98% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 4,522,656 -28,047,346 -86% 30 Sep 2023 10-Q 31 Oct 2023 2023 Q3
Q2 2023 2,879,620 -19,589,062 -87% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 36,123,833 +13,926,198 +63% 31 Mar 2023 10-Q 20 Apr 2023 2023 Q1
Q4 2022 2,240,092 -13,269,933 -86% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 32,570,002 +17,209,977 +112% 30 Sep 2022 10-Q 20 Oct 2022 2022 Q3
Q2 2022 22,468,682 +10,381,157 +86% 30 Jun 2022 10-Q 21 Jul 2022 2022 Q2
Q1 2022 22,197,635 +12,017,110 +118% 31 Mar 2022 10-Q 21 Apr 2022 2022 Q1
Q4 2021 15,510,025 +8,760,997 +130% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q3 2021 15,360,025 +10,768,610 +235% 30 Sep 2021 10-Q 21 Oct 2021 2021 Q3
Q2 2021 12,087,525 +7,813,668 +183% 30 Jun 2021 10-Q 22 Jul 2021 2021 Q2
Q1 2021 10,180,525 +6,299,937 +162% 31 Mar 2021 10-Q 22 Apr 2021 2021 Q1
Q4 2020 6,749,028 +2,868,440 +74% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 4,591,415 +1,749,827 +62% 30 Sep 2020 10-Q 22 Oct 2020 2020 Q3
Q2 2020 4,273,857 +3,977,248 +1341% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 3,880,588 +3,442,472 +786% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 3,880,588 +3,583,979 +1208% 31 Dec 2019 10-K 22 Feb 2021 2020 FY
Q3 2019 2,841,588 -8,849,705 -76% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 296,609 -5,879,445 -95% 30 Jun 2019 10-Q 15 Aug 2019 2019 Q2
Q1 2019 438,116 -61,175,682 -99% 31 Mar 2019 8-K 10 Sep 2019
Q4 2018 296,609 +180,958 +156% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 11,691,293 -23,025,025 -66% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 6,176,054 -27,152,347 -81% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 61,613,798 +37,846,375 +159% 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 115,651 -21,592,239 -99% 31 Dec 2017 8-K 10 Sep 2019
Q3 2017 34,716,318 +14,221,249 +69% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 33,328,401 +12,835,800 +63% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 23,767,423 -176,232,577 -88% 31 Mar 2017 10-Q 12 May 2017 2017 Q1
Q4 2016 21,707,890 +8,703,997 +67% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q3 2016 20,495,069 -137,973,576 -87% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 20,492,601 -130,465,551 -86% 30 Jun 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 200,000,000 +85,902,643 +75% 31 Mar 2016 10-Q 09 Nov 2016 2016 Q3
Q4 2015 13,003,893 -86,344,484 -87% 31 Dec 2015 10-K 24 Mar 2017 2016 FY
Q3 2015 158,468,645 +74,894,481 +90% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 150,958,152 +71,416,377 +90% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 114,097,357 +38,638,806 +51% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 99,348,377 +28,043,002 +39% 31 Dec 2014 10-K 11 Mar 2016 2015 FY
Q3 2014 83,574,164 +16,303,698 +24% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 79,541,775 +12,306,184 +18% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 75,458,551 +8,285,501 +12% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 71,305,375 +5,391,325 +8.2% 31 Dec 2013 10-K 16 Mar 2015 2014 FY
Q3 2013 67,270,466 +10,675,783 +19% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 67,235,591 +8,528,735 +15% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 67,173,050 +8,744,444 +15% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 65,914,050 +9,319,367 +16% 31 Dec 2012 10-K 14 Mar 2014 2013 FY
Q3 2012 56,594,683 +1,760,000 +3.2% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 58,706,856 +6,236,630 +12% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 58,428,606 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 56,594,683 +4,639,418 +8.9% 31 Dec 2011 10-K 15 Mar 2013 2012 FY
Q3 2011 54,834,683 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 52,470,226 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q4 2010 51,955,265 31 Dec 2010 10-K/A 07 Sep 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.